| Financial Year |
March 31 2023 |
| Monetary Funds |
180,336,045.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
418,206,839.59 |
| Advances to Suppliers |
2,842,741.84 |
| Other Receivables |
5,596,287.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
306,711,588.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,161,221.18 |
| Total Current Assets |
1,057,015,176.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
263,747,391.15 |
| Investment Properties |
-- |
| Fixed Assetes |
482,670,724.32 |
| Under-construction Projects |
4,163,963.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
103,437,344.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,045,270.45 |
| Deferred Income Tax Assets |
8,955,770.50 |
| Other Non-Current Assets |
5,499,343.43 |
| Sub-Total of Non-Current Assets |
1,013,371,675.42 |
| Total Assets |
2,070,386,852.07 |
| Short-Term Loans |
285,298,215.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
230,815,710.84 |
| Accounts Payable |
180,401,945.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,416,625.47 |
| Taxes Payable |
23,307,812.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,311,193.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
85,755,999.86 |
| Other Current Liabilities |
327,880.43 |
| Sub-Total of Current Liabilities |
832,110,405.07 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,255,117.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
54,417,431.75 |
| Total Liabilities |
886,527,836.82 |
| Paid-In Capital(Or Share Stock) |
185,651,200.00 |
| Capital Surplus |
232,824,597.54 |
| Surplus Reserve |
70,156,751.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
689,033,958.27 |
| Minority Stockholder's Interest |
6,192,508.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,177,666,506.81 |
| Owner's Equity（Stockholder's Equity） |
1,183,859,015.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,070,386,852.07 |
